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552 Clinical pulmonary autograft valves: Pathologic evidence of adaptive
remodeling in the aortic site
Elena Rabkin-Aikawa, MD, PhD, Masanori Aikawa, MD, PhD, Mark Farber, MS,
Johannes R. Kratz, MS, Guillermo Garcia-Cardena, PhD, Nicholas T. Kouchoukos, MD,
Max B. Mitchell, MD, Richard A. Jonas, MD, and Frederick J. Schoen, MD, PhD, Boston,
Mass; St Louis, Mo; and Denver, Colo
We studied explanted pulmonary autograft valves up to 6 years postoperatively. Autograft cusp
explants showed near-normal morphology, collagen architecture, and cell phenotype. In the
same patients, homograft valve cusps and autograft walls had decreased collagen, elastin, and
overall cell density.
562 Size reduction ascending aortoplasty: Is it dead or alive? }
Francis Robicsek, MD, PhD, Joseph W. Cook, MD, Mark K. Reames, Sr, MD, and
Eric R. Skipper, MD, Charlotte, NC
Reduction ascending aortoplasty is controversial. Some believe that it can be appropriately
applied when the anatomic features are favorable. Others suggest that it should be restricted to
those patients who are at unacceptably high risk for more radical procedures. Yet others believe
that reduction ascending aortoplasty should not be applied at all. The purpose of the article is
to draw conclusions on the applicability of reduction ascending aortoplasty in modern
cardiovascular surgery.
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571 Injectable bioartificial myocardial tissue for large-scale intramural cell
transfer and functional recovery of injured heart muscle
Theo Kofidis, MD, Jorg L. de Bruin, MS, Grant Hoyt, RA, Darren R. Lebl, MS,
Masashi Tanaka, MD, Toshiyuki Yamane, PhD, Ching-Pin Chang, MD, PhD, and
Robert C. Robbins, MD, Stanford, Calif
Seeding labeled embryonic stem cells in a liquid matrix for transplantation into the injured
heart improved fractional shortening and regional contractility. Liquid bioartificial myocardial
tissue constitutes a promising new approach to restoring injured heart muscle without distorting
its geometry and structure.
579 Three-dimensional echocardiography–guided beating-heart surgery without
cardiopulmonary bypass: A feasibility study
Yoshihiro Suematsu, MD, PhD, Gerald R. Marx, MD, Jeffrey A. Stoll, BS,
Pierre E. DuPont, PhD, Robin O. Cleveland, PhD, Robert D. Howe, PhD,
John K. Triedman, MD, Tomislav Mihaljevic, MD, Bassem N. Mora, MD,
Bernie J. Savord, MS, Ivan S. Salgo, MD, MS, and Pedro J. del Nido, MD,
Boston, Cambridge, and Andover, Mass
Real-time 3-dimensional echocardiography provides adequate imaging and anatomic detail to
act as a sole guide for surgical task performance. These initial experiments demonstrate the
feasibility of beating-heart direct or patch closure of ASD and mitral valve plasty without CPB.
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